Literature DB >> 27548630

Proper Use of Inflammatory Bowel Disease Drugs during Pregnancy.

S L Kanis1, C J van der Woude.   

Abstract

Crohn's disease and ulcerative colitis, referred to as inflammatory bowel disease (IBD), are chronic, relapsing conditions. Patients are often diagnosed at a reproductive age, and therefore questions about fertility and reproductions often arise. Preconceptional counseling is the most important aspect in the management of IBD patients with a pregnancy wish. Patients should be counseled on the influence of IBD and IBD drugs on pregnancy. Most drugs are not related to adverse outcome while used during pregnancy. Active disease is related to adverse outcomes; therefore, it is of utmost importance to strive for remission before conception and during pregnancy.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27548630      PMCID: PMC5319597          DOI: 10.1159/000447377

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  62 in total

1.  Fertility and pregnancy in inflammatory bowel disease.

Authors:  M Hudson; G Flett; T S Sinclair; P W Brunt; A Templeton; N A Mowat
Journal:  Int J Gynaecol Obstet       Date:  1997-08       Impact factor: 3.561

2.  Corticosteroid use during pregnancy and risk of orofacial clefts.

Authors:  Anders Hviid; Ditte Mølgaard-Nielsen
Journal:  CMAJ       Date:  2011-04-11       Impact factor: 8.262

Review 3.  Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis.

Authors:  A Waljee; J Waljee; A M Morris; P D R Higgins
Journal:  Gut       Date:  2006-06-13       Impact factor: 23.059

4.  Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis.

Authors:  B Bar Oz; R Hackman; T Einarson; G Koren
Journal:  Transplantation       Date:  2001-04-27       Impact factor: 4.939

5.  Infliximab and semen quality in men with inflammatory bowel disease.

Authors:  Uma Mahadevan; Jonathan P Terdiman; Jeffrey Aron; Steve Jacobsohn; Paul Turek
Journal:  Inflamm Bowel Dis       Date:  2005-04       Impact factor: 5.325

6.  Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study.

Authors:  Jessica Coelho; Laurent Beaugerie; Jean Frédéric Colombel; Xavier Hébuterne; Eric Lerebours; Marc Lémann; Philippe Baumer; Jacques Cosnes; Arnaud Bourreille; Jean Pierre Gendre; Philippe Seksik; Antoine Blain; Etienne H Metman; Andrée Nisard; Guillaume Cadiot; Michel Veyrac; Benoît Coffin; Xavier Dray; Fabrice Carrat; Philippe Marteau
Journal:  Gut       Date:  2010-11-29       Impact factor: 23.059

Review 7.  Sexual and reproductive issues for men with inflammatory bowel disease.

Authors:  Linda A Feagins; Sunanda V Kane
Journal:  Am J Gastroenterol       Date:  2009-02-17       Impact factor: 10.864

8.  Psoriasis, methotrexate, and oligospermia.

Authors:  A Sussman; J M Leonard
Journal:  Arch Dermatol       Date:  1980-02

9.  Effects of discontinuing anti-tumor necrosis factor therapy during pregnancy on the course of inflammatory bowel disease and neonatal exposure.

Authors:  Zuzana Zelinkova; Cokkie van der Ent; Karlien F Bruin; Onno van Baalen; Hestia G Vermeulen; Herman J T Smalbraak; Rob J Ouwendijk; Aad C Hoek; Sjoerd D van der Werf; Ernst J Kuipers; C Janneke van der Woude
Journal:  Clin Gastroenterol Hepatol       Date:  2012-10-25       Impact factor: 11.382

10.  Pregnancy Outcomes in Subjects Exposed to Certolizumab Pegol.

Authors:  Megan E B Clowse; Douglas C Wolf; Frauke Förger; John J Cush; Amanda Golembesky; Laura Shaughnessy; Dirk De Cuyper; Uma Mahadevan
Journal:  J Rheumatol       Date:  2015-11-01       Impact factor: 4.666

View more
  1 in total

1.  Facilitators and barriers of preconception care in women with inflammatory bowel disease and rheumatic diseases: an explorative survey study in a secondary and tertiary hospital.

Authors:  L A C Admiraal; A N Rosman; R J E M Dolhain; R L West; A G M G J Mulders
Journal:  BMC Pregnancy Childbirth       Date:  2022-03-23       Impact factor: 3.007

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.